BWAY Brainsway Ltd
- Stocks
- Healthcare
- NASDAQ: BWAY
Price (delayed)
$11.96
Market cap
$225.01M
P/E Ratio
49.83
Dividend/share
N/A
EPS
$0.24
Enterprise value
$158.7M
brainsway is a leading global neurmodulation company with headquarters in jerusalem and the us. our patented breakthrough technology has already treated over 10,000 patients, and has helped usher in a
Highlights
The P/E is 61% lower than the last 4 quarters average of 127.7
The equity has surged by 52% year-on-year and by 2.3% since the previous quarter
BWAY's quick ratio is up by 15% year-on-year but it is down by 3.3% since the previous quarter
Key stats
What are the main financial stats of BWAY
Market
Valuations
Earnings
Shares outstanding
18.81M
Market cap
$225.01M
Enterprise value
$158.7M
Price to earnings (P/E)
49.83
Price to book (P/B)
3.53
Price to sales (P/S)
5.18
EV/EBIT
25.87
EV/EBITDA
19.88
EV/Sales
3.65
Revenue
$43.46M
Gross profit
$32.38M
Operating income
$1.87M
Net income
$3.92M
EBIT
$6.14M
EBITDA
$7.98M
Free cash flow
$8.09M
Per share
Balance sheet
Liquidity
EPS
$0.24
EPS diluted
$0.14
Free cash flow per share
$0.43
Book value per share
$3.39
Revenue per share
$2.31
TBVPS
$5.33
Total assets
$100.2M
Total liabilities
$36.45M
Debt
$5.57M
Equity
$63.75M
Working capital
$67.81M
Debt to equity
0.09
Current ratio
5.03
Quick ratio
4.68
Net debt/EBITDA
-8.31
Margins
Efficiency
Dividend
EBITDA margin
18.4%
Gross margin
74.5%
Net margin
9%
Operating margin
4.3%
Return on assets
4.7%
Return on equity
7.4%
Return on invested capital
50.8%
Return on capital employed
7.4%
Return on sales
14.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BWAY stock price
How has the Brainsway stock price performed over time
Intraday
1.1%
1 week
0.59%
1 month
-9.05%
1 year
58.83%
YTD
26.83%
QTD
-9.05%
Financial performance
How have Brainsway's revenue and profit performed over time
Revenue
$43.46M
Gross profit
$32.38M
Operating income
$1.87M
Net income
$3.92M
Gross margin
74.5%
Net margin
9%
The operating income has grown by 35% from the previous quarter
BWAY's net income is up by 34% QoQ
Brainsway's gross profit has increased by 27% YoY and by 6% from the previous quarter
The company's net margin rose by 27% QoQ
Price vs fundamentals
How does BWAY's price correlate with its fundamentals
Growth
What is Brainsway's growth rate over time
Valuation
What is Brainsway stock price valuation
P/E
49.83
P/B
3.53
P/S
5.18
EV/EBIT
25.87
EV/EBITDA
19.88
EV/Sales
3.65
The P/E is 61% lower than the last 4 quarters average of 127.7
BWAY's EPS is up by 33% since the previous quarter
The P/B is 66% above the 5-year quarterly average of 2.1 and 25% above the last 4 quarters average of 2.8
The equity has surged by 52% year-on-year and by 2.3% since the previous quarter
BWAY's P/S is 60% above its 5-year quarterly average of 3.2 and 38% above its last 4 quarters average of 3.7
The company's revenue rose by 27% YoY and by 6% QoQ
Efficiency
How efficient is Brainsway business performance
BWAY's ROIC has soared by 81% QoQ
The ROA has grown by 21% from the previous quarter
The ROE has grown by 21% from the previous quarter
BWAY's return on sales is up by 17% since the previous quarter
Dividends
What is BWAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BWAY.
Financial health
How did Brainsway financials performed over time
The total assets is 175% greater than the total liabilities
Brainsway's total liabilities has surged by 57% YoY and by 14% QoQ
The total assets has surged by 54% year-on-year and by 6% since the previous quarter
The company's debt is 91% lower than its equity
The equity has surged by 52% year-on-year and by 2.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.